Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity.
Glucose, insulin and somatostatin infusion over 2 hours effectively suppressed endogenous secretion of insulin, glucagon and growth hormones. Steady state plasma glucose level (SSPG) which should be inversely proportional to insulin sensitivity was obtained. In 6 adult-onset non-obese untreated diabetics, mean value of insulin sensitivity indices was significantly reduced compared with normal. In 5 insulin-treated diabetics and in 5 subjects with borderline glucose tolerance including 2 obese subjects, insulin sensitivity for glucose utilization was also significantly diminished.
D001786:Blood Glucose / Q000032:analysis*; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy; D005947:Glucose / Q000008:administration & dosage*; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D013004:Somatostatin / Q000008:administration & dosage*
D001786:Blood Glucose; D007328:Insulin; D049528:Insulin, Long-Acting; D013004:Somatostatin; D005947:Glucose